TSEN34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.094200E-01
Normal-vs-Stage2
6.257800E-01
Normal-vs-Stage3
6.015600E-01
Normal-vs-Stage4
3.507400E-01
Stage1-vs-Stage2
6.473800E-01
Stage1-vs-Stage3
2.329800E-01
Stage1-vs-Stage4
4.252400E-01
Stage2-vs-Stage3
2.602200E-01
Stage2-vs-Stage4
3.142000E-01
Stage3-vs-Stage4
1.976640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.028600E-01
Normal-vs-AfricanAmerican
7.768600E-01
Normal-vs-Asian
3.923200E-01
Caucasian-vs-AfricanAmerican
8.679000E-01
Caucasian-vs-Asian
3.612400E-01
AfricanAmerican-vs-Asian
5.554000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.298800E-01
Normal-vs-Female
6.650800E-01
Male-vs-Female
7.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.043400E-01
Normal-vs-Age(41-60Yrs)
4.236600E-01
Normal-vs-Age(61-80Yrs)
6.951800E-01
Normal-vs-Age(81-100Yrs)
7.597800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.838600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.322400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.622400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.932200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.641700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.249400E-01
Normal-vs-Daily Drinker
3.369800E-01
Normal-vs-Weekly Drinker
3.482600E-01
Normal-vs-Occasional Drinker
1.614170E-01
Normal-vs-Social Drinker
6.521600E-01
Non Drinker-vs-Daily Drinker
1.689610E-01
Non Drinker-vs-Weekly Drinker
2.629400E-01
Non Drinker-vs-Occasional Drinker
6.584300E-02
Non Drinker-vs-Social Drinker
7.814600E-01
Daily Drinker-vs-Weekly Drinker
9.581200E-01
Daily Drinker-vs-Occasional Drinker
4.849600E-01
Daily Drinker-vs-Social Drinker
1.216840E-01
Weekly Drinker-vs-Occasional Drinker
4.901200E-01
Weekly Drinker-vs-Social Drinker
1.890570E-01
Occasional Drinker-vs-Social Drinker
2.829700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.811800E-01
Normal-vs-Grade 2
8.857200E-01
Normal-vs-Grade 3
9.328200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.280400E-01
Grade 1-vs-Grade 3
4.390200E-01
Grade 1-vs-Grade 4
8.811800E-01
Grade 2-vs-Grade 3
3.319800E-01
Grade 2-vs-Grade 4
8.857200E-01
Grade 3-vs-Grade 4
9.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.853600E-01
Normal-vs-NonDiabetic
4.638400E-01
Diabetic-vs-NonDiabetic
8.543800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.243600E-01
Normal-vs-NoPancreatitis
5.834600E-01
Pancreatitis-vs-NoPancreatitis
2.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.556200E-01
Normal-vs-N1
6.525400E-01
N0-vs-N1
6.222800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.424400E-01
Normal-vs-TP53-NonMutant
7.214600E-01
TP53-Mutant-vs-TP53-NonMutant
1.54236999999613E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
